News

A tumor often arises when cancer genes multiply. In this process, additional genes act as hitchhikers, potentially creating previously unknown vulnerabilities that open the door to new therapeutic approaches. This finding is reported by a team led by ECRC-scientists Anton Henssen and Jan Dörr in "Cancer Discovery."

About 30 young people are currently pursuing vocational training or a dual-study program at the Max Delbrück Center. Christiane Busch is one of their instructors. She welcomes the trainees, supports them during their time at the Max Delbrück Center, and finally sends them off into professional life.

Scientific infrastructure is highly specialized and energy-intensive. During a kick-off event of the Helmholtz Competence Network for Climate-Friendly Construction in Berlin, experts from both the Helmholtz centers and the construction industry discussed how it can be designed to be climate-friendly.

Working in Berlin-Mitte and New York – Lena Nitsch conducts research at both the MDC-BIMSB and New York University. For “We at the MDC”, the doctoral student discusses how it is to work in two labs, her experiences in the United States, and what she has learned through the “MDC-NYU PhD Exchange Program”.

The European Molecular Biology Organization has selected Leif. S. Ludwig from the Berlin Institute of Health at Charité (BIH) and the Max Delbrück Center to become an EMBO Young Investigator. The program provides support to outstanding young life scientists.

For his work on aggressive glioblastomas, Dr. Gaetano Gargiulo of the Max Delbrück Center received a 10,000 euro prize from the Berlin-Brandenburg Academy of Sciences and Humanities. Donated by the Monika Kutzner Stiftung, the prize honors outstanding achievements in cancer research.

From 2024, the Federal Government and the State of Berlin will fund the establishment of the National Center for Tumor Diseases (NCT) Berlin. The new site is a cooperation between DKFZ and Charité, BIH, and Max Delbrück Center aimed at closely integrating clinical and translational cancer research.

Simon Haas has been awarded the Lisec-Artz Prize, endowed with €10,000, for his single-cell analysis of communication between stem and immune cells in blood cancer. The University of Bonn Foundation established this prize to honor outstanding early-career cancer researchers.

Swapping just a single amino acid can play a decisive role in transforming healthy B cells into cancer cells. An international team led by ECRC researcher Stephan Mathas describes in “Nature Communications” how a point mutation in the transcription factor IRF4 profoundly alters gene regulation.

Scientists have created a new zebrafish xenograft platform to screen for novel treatments for an aggressive brain tumor called glioblastoma, according to a new study by the Gerhardt and De Smet labs published in “EMBO Molecular Medicine.”